Skip to content
Clinical Trials – home

Johanniter GmbH Johanniter-Krankenhaus

Verifiedinfo

Germany Johanniterstrasse 3-5, Zentrum, 53113 Bonn, Germany

  • 11 trials recruiting
  • Plasma cell myeloma · Breast cancer · Breast cancer female
  • Adult patients

About Specializations

Johanniter GmbH Johanniter-Krankenhaus in Bonn, Germany specialises in clinical trials of conditions such as Plasma cell myeloma, Breast cancer, Breast cancer female, Non-small cell lung cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Gastroenterology and Surgical Innovations

The medical center is at the forefront of gastroenterology research, with a particular focus on improving surgical outcomes for complex procedures such as pancreatoduodenectomy. The center's research aims to enhance patient recovery and reduce complications associated with these surgeries.

  • Delayed Gastric Emptying (DGE) Management
  • Transcutaneous Nicotine Administration
  • Postoperative Recovery Optimization

Through innovative approaches like the transcutaneous administration of nicotine, the center is exploring new methods to mitigate the severity of DGE, thereby contributing to the advancement of surgical care and patient quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Johanniterstrasse 3-5, Zentrum53113 BonnGermany
Recruiting now
11 trials
Conditions studied
31
Partner status
Verified

More sites in BonnGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

24 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Eli Lilly & Co.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:VISUGROMAB
  • Sponsor:CatalYm GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Summit Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Elacestrant
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Merck Sharp & Dohme LLC
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Blinatumomab
  • Sponsor:Goethe University Frankfurt
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Charite Universitaetsmedizin Berlin KöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Universitaetsklinikum Heidelberg AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Disitamab Vedotin
  • Sponsor:Seagen Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.